Genui invests in Labor Team W

The GP is investing alongside Labor Team W's management in a management buy-in that will see the GP take a majority stake in the business.

Alain Cahen is to take over the role of CEO as part of the formation of a new management team, while Jörg Debatin will take on the role of chairman of the board.

Genui is deploying equity via Genui Fund II, which held a final close in December 2019 on €700m, according to Unquote Data. The vehicle deploys equity tickets of €20-150m. Labor Team W will be the fund's fifth platform investment, a source close to the situation told Unquote.

The GP said in a statement that the aim of the MBI is to strengthen and expand Labor Team W's position in the Swiss market.

Another PE-backed diagnostics company recently in the news was Synlab, which listed in May 2021 with a valuation of €5bn; the company had previous backing from Cinven, Novo Holdings and Ontario Teachers' Pension Plan.

Company
Labor Team W is a medical laboratory that offers testing services for the diagnosis, prevention, monitoring and treatment of diseases. Headquartered in Goldach, the company was founded in 2000 and employs 400 staff.

People
Genui – Andreas Jacobs (founding partner).
Labor Team W – Martin Wyss (founder, former CEO); Jörg Debatin (chairman, co-owner); Alain Cahen (CEO, co-owner).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• DACH
• Industrials
• Switzerland
• Management Buy-in